Green Cross Medical Science Corporation (KOSDAQ: 142280)
South Korea
· Delayed Price · Currency is KRW
4,025.00
+105.00 (2.68%)
Sep 11, 2024, 10:05 AM KST
Green Cross Medical Science Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 86,828 | 100,562 | 121,856 | 152,316 | 330,756 | 110,603 | |
Market Cap Growth | -14.59% | -17.47% | -20.00% | -53.95% | 199.05% | -6.70% | |
Enterprise Value | 113,692 | 119,151 | 134,083 | 193,496 | 343,759 | 149,852 | |
Last Close Price | 4000.00 | 4770.00 | 5780.00 | 7230.00 | 15700.00 | 5250.00 | |
PE Ratio | 271.47 | 62.93 | -34.00 | -7.18 | 49.24 | -3.58 | |
PS Ratio | 0.88 | 1.07 | 1.08 | 1.50 | 2.92 | 1.36 | |
PB Ratio | 2.37 | 2.72 | 3.42 | 4.02 | 5.69 | 2.18 | |
P/FCF Ratio | -31.60 | -72.32 | 16.35 | -6.99 | -29.23 | -4.16 | |
P/OCF Ratio | 21.57 | 23.71 | 11.20 | -8.37 | -37.76 | -26.93 | |
EV/Sales Ratio | 1.18 | 1.27 | 1.19 | 1.90 | 3.03 | 1.84 | |
EV/EBITDA Ratio | 26.39 | 23.25 | 58.33 | -11.85 | 46.70 | -3400.39 | |
EV/EBIT Ratio | 275.56 | 93.70 | -74.15 | -9.60 | 81.88 | -49.68 | |
EV/FCF Ratio | -44.34 | -85.68 | 17.99 | -8.88 | -30.38 | -5.64 | |
Debt / Equity Ratio | 0.81 | 0.61 | 0.66 | 0.97 | 0.31 | 0.25 | |
Debt / EBITDA Ratio | 7.17 | 4.41 | 10.18 | - | 2.45 | - | |
Debt / FCF Ratio | -12.05 | -16.24 | 3.14 | -1.70 | -1.60 | -0.48 | |
Asset Turnover | 1.00 | 1.01 | 1.18 | 1.01 | 1.17 | 1.07 | |
Inventory Turnover | 4.97 | 5.38 | 4.68 | 3.78 | 5.11 | 6.11 | |
Quick Ratio | 0.58 | 0.58 | 0.80 | 0.47 | 0.87 | 1.22 | |
Current Ratio | 0.96 | 0.93 | 1.27 | 1.07 | 1.57 | 1.63 | |
Return on Equity (ROE) | 3.10% | 5.17% | -8.31% | -43.99% | 12.90% | -33.68% | |
Return on Assets (ROA) | 0.24% | 0.85% | -1.18% | -12.53% | 2.70% | -2.47% | |
Return on Capital (ROIC) | 0.36% | 1.34% | -1.69% | -16.68% | 3.76% | -3.59% | |
Earnings Yield | 0.37% | 1.79% | -2.94% | -13.92% | 2.03% | -14.65% | |
FCF Yield | -2.95% | -1.38% | 6.12% | -14.31% | -3.42% | -24.02% | |
Buyback Yield / Dilution | -765.73% | -26.96% | -0.05% | - | -90.86% | -16.07% | |
Total Shareholder Return | -765.73% | -26.96% | -0.05% | - | -90.86% | -16.07% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.